Published in Am J Emerg Med on February 01, 2010
The Association between Diabetic Retinopathy and Levels of Ischemia-Modified Albumin, Total Thiol, Total Antioxidant Capacity, and Total Oxidative Stress in Serum and Aqueous Humor. J Ophthalmol (2014) 0.75
The Diagnostic Value of β-Human Chorionic Gonadotropin, Progesterone, and Ischemia-Modified Albumin and Their Combined Use in the Prediction of First Trimester Abortions. Int Sch Res Notices (2014) 0.75
Prognostic utility of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI). Int J Emerg Med (2011) 0.75
Ischaemia modified albumin: Does it bolster our diagnostic ammunition? Indian J Anaesth (2011) 0.75
Role of "Ischemia Modified Albumin" (IMA) in acute coronary syndromes. Indian Heart J (2014) 0.75
Universal definition of myocardial infarction. Circulation (2007) 11.69
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem (2005) 2.43
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA (2008) 2.39
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet (2010) 2.38
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation (2007) 2.37
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation (2006) 2.09
Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol (2010) 1.93
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem (2007) 1.82
Quality specifications for B-type natriuretic peptide assays. Clin Chem (2005) 1.81
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial). Am J Cardiol (2012) 1.59
Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem (2003) 1.51
Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart (2013) 1.47
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease. Thromb Haemost (2005) 1.46
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial. EuroIntervention (2011) 1.43
Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention. EuroIntervention (2012) 1.42
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation (2007) 1.39
Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results. J Am Coll Cardiol (2013) 1.14
Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation (2009) 1.13
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol (2008) 1.08
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial. J Am Coll Cardiol (2010) 1.04
Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation (2008) 1.02
Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study. Circ Cardiovasc Interv (2009) 0.98
Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention. Circ Cardiovasc Interv (2012) 0.96
Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy). Am J Cardiol (2011) 0.95
Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism. Blood (2012) 0.92
A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem Lab Med (2009) 0.91
A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res (2003) 0.90
Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest--a systematic review and meta-analysis. Resuscitation (2012) 0.90
Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study. EuroIntervention (2013) 0.89
Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem (2011) 0.88
A porcine model of massive, totally occlusive, pulmonary embolism. Thromb Res (2009) 0.88
2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial. J Am Coll Cardiol (2012) 0.86
Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology. Clin Epidemiol (2013) 0.86
Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med (2010) 0.85
Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry, VerifyNow, and thrombelastography in patients undergoing percutaneous coronary intervention. Clin Chem (2010) 0.85
Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results. EuroIntervention (2008) 0.84
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction. Circ Cardiovasc Interv (2011) 0.84
Elevated thyroid-stimulating hormone level in a euthyroid neonate caused by macro thyrotropin-IgG complex. Acta Paediatr (2011) 0.84
Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol (2011) 0.83
Reference genes for gene expression analysis by real-time reverse transcription polymerase chain reaction of renal cell carcinoma. Diagn Mol Pathol (2011) 0.83
Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays. Clin Chim Acta (2010) 0.82
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction). JACC Cardiovasc Interv (2013) 0.81
Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia. Clin Chim Acta (2009) 0.81
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents. JACC Cardiovasc Interv (2012) 0.81
Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization. Int J Cardiol (2007) 0.81
Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity. Blood (2002) 0.81
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy. Eur J Clin Invest (2012) 0.81
Mathematical modelling of the acid-base chemistry and oxygenation of blood: a mass balance, mass action approach including plasma and red blood cells. Eur J Appl Physiol (2009) 0.81
Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Eur Heart J (2015) 0.81
Haematoma after coronary angiography and percutaneous coronary intervention via the femoral artery frequency and risk factors. Eur J Cardiovasc Nurs (2005) 0.80
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial. Circ Cardiovasc Interv (2014) 0.79
Determinants of the release pattern of ischaemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI. Scand J Clin Lab Invest (2010) 0.78
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation. EuroIntervention (2012) 0.78
Extracorporeal cardiopulmonary support may be an efficient rescue of patients after massive pulmonary embolism. An experimental porcine study. Thromb Res (2012) 0.78
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry. EuroIntervention (2010) 0.78
Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era. Scand Cardiovasc J (2007) 0.77
Variation and importance of aspirin resistance in patients with known cardiovascular disease. Thromb Res (2006) 0.77
A method for estimation of plasma albumin concentration from the buffering properties of whole blood. J Crit Care (2012) 0.77
[Coronary angiography should be considered after out-of-hospital cardiac arrest]. Ugeskr Laeger (2011) 0.77
Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy. Thromb Haemost (2007) 0.77
Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease. Cardiology (2010) 0.77
Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study. Arch Dis Child Fetal Neonatal Ed (2012) 0.77
Reference intervals and age and gender dependency for arterial blood gases and electrolytes in adults. Clin Chem Lab Med (2011) 0.77
Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results. JACC Cardiovasc Interv (2013) 0.76
Alcohol intake and risk of venous thromboembolism. A Danish follow-up study. Thromb Haemost (2013) 0.76
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy). BMC Cardiovasc Disord (2012) 0.75
[Retirement of creatinine kinase myocardial band is not recommended]. Ugeskr Laeger (2008) 0.75
Effect of exercise on platelet activation during aspirin or clopidogrel intake in healthy men. Platelets (2009) 0.75
Platelet response to aspirin and clopidogrel in patients with peripheral atherosclerosis. Platelets (2011) 0.75
[Venous thromboembolism in children]. Ugeskr Laeger (2008) 0.75
Extra corporeal life support makes advanced radiologic examinations and cardiac interventions possible in patients with cardiac arrest. Resuscitation (2011) 0.75
Data mining to assess variations in oral anticoagulant treatment. Stud Health Technol Inform (2010) 0.75
Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants. Nephrol Dial Transplant (2005) 0.75
Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial. J Nucl Cardiol (2009) 0.75
Monitoring of anticoagulant therapy applying a dynamic statistical model. Comput Methods Programs Biomed (2013) 0.75
Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE). Clin Chem Lab Med (2013) 0.75
Biochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: experiences from the Nordic countries. Scand Cardiovasc J (2005) 0.75
Hemizygous antithrombin-deficiency (Budapest III) in a newborn presenting with a thrombosis at birth. Br J Haematol (2007) 0.75
Unrecognized preanalytical problem with the spectrophotometric analysis of cerebrospinal fluid for xanthochromia. Clin Chem (2008) 0.75
Novel uses for platelet function testing in the clinical laboratory: where are we now? Clin Chem (2013) 0.75
A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome. Scand J Clin Lab Invest (2010) 0.75
How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study. Clin Chem (2008) 0.75
Denaturing high-performance liquid chromatography mutation analysis in patients with reduced Protein S levels. Clin Chim Acta (2008) 0.75
Quality assurance of the Western Denmark Heart Registry, a population-based healthcare register. Dan Med J (2017) 0.75
Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic(R), Express(R), and Flexmaster(R) coronary stents. EuroIntervention (2005) 0.75
[Challenges of the antithrombotic treatment. The Danish Society for Thrombosis and Hemostasis]. Ugeskr Laeger (2008) 0.75